In the trial, participants who were 50 years of age or older, had type 2 diabetes with a glycated hemoglobin level of 6.5 to 10.0%, and had known atherosclerotic cardiovascular disease, chronic kidney disease, or both received either once-daily oral semaglutide (maximal dose, 14 mg) or placebo, in addition to standard care
In cirrhosis patients, doses around 1.274 g per day for nearly one year were also safe
Some compounding pharmacies may use tirzepatide salts, which are not safe or source their ingredients from unregistered or unverified manufacturers, raising potential safety risks
At first, digestive troubles like nausea, bloating, or constipation might show up while your body gets used to the medication
Avoid combining topiramate with other carbonic anhydrase inhibitors unless closely supervised
Ihr Speicher kann bis zu 25 Gramm des Stoffs aufnehmen, whrend Frauen nur etwa 20 Gramm speichern knnen